Related Experiment Video
Updated: Apr 28, 2026

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Explaining end-users' intentions to use innovative medical and food biotechnology products
Bob C Mulder1, P Marijn Poortvliet, Peter Lugtig
1Strategic Communication, Wageningen University, The Netherlands. bob.mulder@wur.nl.
Abstract:
Low public acceptance hinders the successful introduction of biotechnological innovations, such as genetically modified foods or vaccinations against infectious diseases. Earlier studies indicated that a lack of knowledge is not a key barrier to acceptance. This was confirmed in the current study, which examined an integrated theoretical model tested among 579 participants from the Dutch public. The results suggest that communication strategies should instead target attitudes, social norms, and risk perceptions, and appeal to people's tendency (or lack thereof) to be innovative.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Plant Breeding and Biotechnology
Recombinant DNA
Upstream Processing
Bioavailability Study Design: Healthy Subjects Versus Patients
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

